September 11, 2015
Chemo-Sero-Therapeutic Research Institute (Kaketsuken) on September 9 announced the results of its internal investigation into its use of unapproved manufacturing methods for plasma fraction products derived from blood donated in Japan. The investigation, conducted by Kaketsuken with the participation of...read more